Privia Health Group Inc (PRVA) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Privia Health Group Inc   (NASDAQ: PRVA)


Privia Health Group Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Privia Health Group Inc's ROI in the third quarter of 2026?
Privia Health Group Inc achieved a return on average invested assets (ROI) of 4.2 % in its third quarter of 2026, this is above PRVA's average return on investment of -2.83%.
Privia Health Group Inc invested over the 12 months ending in its third quarter of 2026 $893 million

ROI has improved compared to 3.93% in the second quarter of 2026, due to net income growth.

Within the Healthcare sector 76 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2026 quarter, so far to 1780, from total ROI ranking in the second quarter of 2026 at 1951.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 15.49 % 15.37 % 14.7 % 14.5 % 13.55 %
Y / Y Net Income Change TTM 53.08 % 81.14 % 77.96 % 218.1 % 516.09 %
Investment (TTM) in Millions 947 910 869 847 818
Return On Investment (TTM) 4.2 % 3.93 % 3.3 % 3.7 % 3.17 %
PRVA's Overall Ranking # 1780 # 1951 # 1710 # 1783 # 1707
Seq. Investment Change TTM 3.73 % 3.79 % 3.42 % 3.73 % 3.63 %
Seq. Net Income Change TTM 10.88 % 23.53 % -7.86 % 21.29 % 31.21 %
Net Income (TTM) in Millions 38 34 27 30 25

PRVA Company Profile >> Back to PRVA Roi Comparisons >> See Annual PRVA Return On Investment



Return On Investment PRVA's Ranking
Within: No.
Industry # 22
Sector # 77
Overall # 1780

Return On Investment Statistics
High Average Low
11.96 %
-2.83 %
-48.5 %
  (Dec 31 2021)



  News about Privia Health Group Inc Return on Investment ROI

Privia Healths $176.6 Million Milestone: Navigating Challenges and Achievements in the Medicare Shared Savings Arena,

October 29, 2024

Privia Health Reports Strong Performance in Medicare Shared Savings Program: A Closer Look at Financial Results and TrendsPrivia Health Group Inc. has recently announced its performance results for the Medicare Shared Savings Program (MSSP) in 2023, revealing noteworthy achievements and financial metrics that underline the company’s position within the competitive healthcare sector. With an impressive total of $176.6 million in shared savings delivered across ten participating Accountable Care Organizations (ACOs), Privia Health is successfully navigating the complexities of value-based care. A Promising Show in Shared SavingsThe shared savings achieved by Privia Health in the Medicare Shared Savings Program reflect the company’s commitment to improving patient outcomes and reducing healthcare costs. Privia s $176.6 million in savings is a significant figure that underscores the efficacy of their operational model, focusing on enhancing healthcare delivery through coordination and improved patient engagement. These results not only represent a financial success for the company but also highlight the broader impact of their initiatives on the healthcare landscape.





Financial Statements
Privia Health Group Inc's III. Quarter Investments $ 947 Millions PRVA's Balance sheet
Privia Health Group Inc's III. Quarter Income $ 13 Millions Quarterly PRVA's Income Statement
PRVA's Income by Division See PRVA's Income by Division


PRVA Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 847 732 654 540 508
Y / Y Investment Growth 15.77 % 11.97 % 21.05 % 6.26 % -
Net Income in Millions 30 17 21 -12 -191
Y / Y Net Income Growth 74.41 % -18.95 % - - -
Annual Return On Investment 3.51 % 2.33 % 3.22 % -2.23 % -37.52 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 3.51 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PRVA's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PRVA's Competitors
Subscribers only: Roi for Privia Health Group Inc's Suppliers
Subscribers only: Return On Investment for PRVA's Customers

Other Ratios
PRVA's Roa PRVA's Inventory Turnover Ratio PRVA's Growth Rates PRVA's Dividend Statistics
PRVA's Profitability Ratios PRVA's Asset Turnover Ratio PRVA's Dividend Growth
PRVA's Roe PRVA's Valuation Ratios PRVA's Financial Strength Ratios PRVA's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Bioventus Inc   11.26 %
Tenet Healthcare Corp  10.91 %
Bio rad Laboratories Inc   10.59 %
Lemaitre Vascular Inc   10.56 %
Johnson and Johnson  10.53 %
Encompass Health Corporation  10.41 %
Ani Pharmaceuticals Inc  9.61 %
Tactile Systems Technology Inc   9.27 %
Boston Scientific Corporation  9.14 %
Brightspring Health Services Inc   9.01 %
Stryker Corp  8.63 %
Pediatrix Medical Group Inc   8.37 %
Penumbra Inc  8.28 %
Medinotec Inc   8.12 %
Pacific Health Care Organization Inc  8.09 %
Quest Diagnostics Inc  8.01 %
Ge Healthcare Technologies Inc   7.60 %
Incyte Corporation  6.81 %
Merit Medical Systems Inc  6.21 %
Davita Inc   6.13 %
Black Hawk Acquisition Corporation  6.10 %
Iqvia Holdings Inc   6.09 %
Labcorp Holdings Inc   6.07 %
Pacs Group Inc   5.95 %
Ensign Group Inc  5.94 %
Amneal Pharmaceuticals Inc   5.59 %
Sotera Health Company  5.43 %
Henry Schein Inc   5.27 %
Abbott Laboratories  5.14 %
Haemonetics Corporation  4.85 %

Date modified: 2026-11-06T13:03:23+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.